Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 59,518 | 45,736 | 55,357 | 46,245 | 53,384 |
| Cost of Goods | 14,918 | 10,844 | 11,896 | 10,279 | 11,969 |
| Gross Profit | 44,600 | 34,892 | 43,461 | 35,966 | 41,415 |
| Operating Expenses | 33,460 | 36,483 | 37,626 | 45,199 | 59,017 |
| Operating Income | 12,058 | -747 | 6,731 | -8,954 | -16,633 |
| Interest Expense | 2,702 | 2,664 | 2,718 | 3,121 | 3,518 |
| Other Income | 72 | 45 | 322 | -32,560 | 15,083 |
| Pre-tax Income | 9,428 | -3,366 | 4,335 | -44,635 | -5,068 |
| Income Tax | 57 | 37 | 211 | 37 | 38 |
| Net Income Continuous | 9,371 | -3,403 | 4,124 | -44,672 | -5,106 |
| Net Income | $9,371 | $-3,403 | $4,124 | $-44,672 | $-5,106 |
| EPS Basic Total Ops | 0.21 | -0.08 | 0.09 | -1.09 | -0.13 |
| EPS Basic Continuous Ops | 0.21 | -0.08 | 0.09 | -1.09 | -0.13 |
| EPS Diluted Total Ops | 0.21 | -0.08 | 0.10 | -1.09 | -0.13 |
| EPS Diluted Continuous Ops | 0.21 | -0.08 | 0.10 | -1.09 | -0.13 |
| EBITDA(a) | $14,519 | $1,710 | $9,709 | $-6,513 | $-13,698 |